AEterna Zentaris to Present at Upcoming 27th Annual Canaccord Adams Global Growth Conference in Boston
August 02 2007 - 7:30AM
PR Newswire (US)
QUEBEC, Aug. 2 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc.
(TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company
focused on endocrine therapy and oncology, today announced that its
Senior Vice President and Chief Financial Officer, Dennis Turpin,
will present a Company overview at the 27th Annual Canaccord Adams
Global Growth Conference on Thursday, August 9, 2007 at 9:30 a.m.
Eastern, in the San Francisco Room of the InterContinental Boston
Hotel, in Boston Massachusetts. About AEterna Zentaris Inc. AEterna
Zentaris Inc. is global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug
discovery, development and commercialization. News releases and
additional information are available at
http://www.aeternazentaris.com/. DATASOURCE: AETERNA ZENTARIS INC.
CONTACT: Jenene Thomas, Senior Director, Investor Relations &
Corporate Communications, (908) 938-1475, ; Paul Burroughs, Media
Relations, (418) 652-8525 ext. 406,
Copyright